Brokers Set Expectations for Cresco Labs Q3 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF - Free Report) - Research analysts at Alliance Global Partners upped their Q3 2025 earnings per share (EPS) estimates for Cresco Labs in a research note issued to investors on Wednesday, March 12th. Alliance Global Partners analyst A. Grey now expects that the company will earn ($0.02) per share for the quarter, up from their prior forecast of ($0.03). The consensus estimate for Cresco Labs' current full-year earnings is ($0.20) per share. Alliance Global Partners also issued estimates for Cresco Labs' Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.09) EPS and FY2026 earnings at ($0.08) EPS.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last released its quarterly earnings data on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The firm had revenue of $176.00 million during the quarter, compared to analyst estimates of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%.

A number of other equities research analysts also recently commented on the company. Cormark upgraded Cresco Labs from a "hold" rating to a "moderate buy" rating in a research report on Monday. Atb Cap Markets downgraded Cresco Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, December 9th. Two equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $3.00.

Remove Ads

Cresco Labs Price Performance

Shares of OTCMKTS:CRLBF traded up $0.01 during mid-day trading on Monday, reaching $0.72. The stock had a trading volume of 2,218,801 shares, compared to its average volume of 621,663. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. The company has a market cap of $349.02 million, a P/E ratio of -3.58 and a beta of 1.79. Cresco Labs has a 1 year low of $0.70 and a 1 year high of $2.60. The business's 50 day moving average price is $0.87 and its 200 day moving average price is $1.18.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.